Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
Onyx Pharmaceuticals, Inc.: Company Profile and SWOT Analysis
Market Briefing
Published: November 2011
Pages: 34
Tables: For full details, please email deborahf@cmsinfo.com
From: GBP 61.88 Buy Now!
Research from: pharmaceuticalmarketresearch
Sector: Corporate & Fiscal
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
ICD Research's "Onyx Pharmaceuticals, Inc.: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Synopsis
ICD Research's "Onyx Pharmaceuticals, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, financial ratios, plus information on key news events affecting the company.
Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
ICD Research's "Onyx Pharmaceuticals, Inc.: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
? Examines and identifies key information and issues about Onyx Pharmaceuticals, Inc. for business intelligence requirements
? Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
? The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.
? The profile also contains information on business operations, company history, major products and services, prospects, key employees.
Reasons To Buy
? Quickly enhance your understanding of the company
? Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
? Increase business/sales activities by understanding your competitors? businesses better
? Recognize potential partnerships and suppliers
? Obtain yearly profitability figures
Key Highlights
Onyx Pharmaceuticals, Inc. (Onyx) is a biopharmaceutical company engaged in developing product candidates for the treatment of indications in oncology on the basis of its proprietary virus technology. The company is developing innovative therapies, which target the molecular mechanisms that cause cancer. Its lead product is Nexavar tablet, a novel, oral multiple kinase inhibitors used for the treatment of kidney and liver cancers. The product, Nexavar, has gained approval in 90 countries for treating patients having unresectable liver cancer, and in over 95 countries for treating patients with advanced kidney cancer. Its other focus areas include proteasome inhibition development. The company is headquartered in Emeryville, California, the US.
ICD Research's "Onyx Pharmaceuticals, Inc.: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Synopsis
ICD Research's "Onyx Pharmaceuticals, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, financial ratios, plus information on key news events affecting the company.
Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
ICD Research's "Onyx Pharmaceuticals, Inc.: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
? Examines and identifies key information and issues about Onyx Pharmaceuticals, Inc. for business intelligence requirements
? Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
? The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.
? The profile also contains information on business operations, company history, major products and services, prospects, key employees.
Reasons To Buy
? Quickly enhance your understanding of the company
? Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
? Increase business/sales activities by understanding your competitors? businesses better
? Recognize potential partnerships and suppliers
? Obtain yearly profitability figures
Key Highlights
Onyx Pharmaceuticals, Inc. (Onyx) is a biopharmaceutical company engaged in developing product candidates for the treatment of indications in oncology on the basis of its proprietary virus technology. The company is developing innovative therapies, which target the molecular mechanisms that cause cancer. Its lead product is Nexavar tablet, a novel, oral multiple kinase inhibitors used for the treatment of kidney and liver cancers. The product, Nexavar, has gained approval in 90 countries for treating patients having unresectable liver cancer, and in over 95 countries for treating patients with advanced kidney cancer. Its other focus areas include proteasome inhibition development. The company is headquartered in Emeryville, California, the US.